4//SEC Filing
Mensinger Mike 4
Accession 0002048500-26-000002
CIK 0001674632other
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 6:05 PM ET
Size
7.1 KB
Accession
0002048500-26-000002
Insider Transaction Report
Form 4
Mensinger Mike
Chief Product Officer
Transactions
- Sale
Common Stock
2026-01-02$29.56/sh−7,200$212,832→ 83,552 total - Sale
Common Stock
2026-01-02$30.20/sh−600$18,118→ 82,952 total
Footnotes (3)
- [F1]Represents shares sold pursuant to a Rule 10b5-1 Plan adopted on September 8, 2025.
- [F2]The weighted average sale price for the transaction reported was $29.56 and the range of prices were between $29.05 and $30.02. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
- [F3]The weighted average sale price for the transaction reported was $30.1969 and the range of prices were between $30.10 and $30.52. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price will be provided.
Documents
Issuer
Beta Bionics, Inc.
CIK 0001674632
Entity typeother
Related Parties
1- filerCIK 0002048500
Filing Metadata
- Form type
- 4
- Filed
- Jan 4, 7:00 PM ET
- Accepted
- Jan 5, 6:05 PM ET
- Size
- 7.1 KB